Hexa, the Paris-based startup studio that recently raised $22 million, is launching a brand new vertical centered on bettering the healthcare system. Julien Méraud, a senior staff member of the French unicorn startup Doctolib, is becoming a member of the startup studio .
As a reminder, Hexa began its life as eFounders and initially centered particularly on B2B software-as-a-service startups. The studio comes up with startup concepts, discover startup founders to pair them with these concepts and assist them get began with its personal core staff and a few preliminary funding.
After some time, startups “graduate” from the startup studio and proceed their life as impartial corporations — Hexa retains a stake in its portfolio corporations. A few of Hexa’s previous corporations embrace Entrance, Aircall and Spendesk.
As Hexa begins to department out to different verticals, the startup studio can also be rethinking its technique. For the well being vertical, Hexa just isn’t solely hiring Julien Méraud. Additionally it is going to work with a full-time medical physician to assist relating to assessing future initiatives.
For every healthtech startup, Hexa goes to be searching for two co-founders — a health care provider who already is aware of their speciality and has hands-on expertise in addition to an operational founder who is aware of learn how to scale corporations.
Hexa Well being could have a vertical strategy with every firm specializing in one pathology particularly. The primary two startups that may come out of the studio will give attention to weight reduction and pores and skin most cancers detection.
“The idea is to have a CEO and a CTO — just like in most startups. And that’s quite common across all Hexa companies. But something that’s a bit new with this particular vertical is that we believe innovation in healthcare should be driven by doctors. In other words, if you ask me to design the perfect care to detect skin cancer, I’m not capable of doing it. That’s why we want to work with doctors on every innovation,” Méraud informed me.
He additionally insists on the truth that Hexa doesn’t need to disrupt the healthcare business as an entire. With this new vertical, the startup studio needs to search out inefficiencies and enhance the care pathways as there’s a rising imbalance between an growing older inhabitants in Europe and the accessible medical time.
“Tech shouldn’t just enable faster care. It should also enable better care. And we’re really going to focus on measuring the medical quality of care and everything we create,” Méraud mentioned.
